There is a growing interest in the development of lipid-based nanocarriers for multiple
purposes, including the recent increase of these nanocarriers as vaccine components …

Despite continuous improvements in delivery systems, the development of methods for
efficient and specific delivery of targeted therapeutic agents still remains an issue in …

Nanoparticles (NPs) are one of the leading and promising technologies for gene and drug
delivery. However, despite continuous advancements in the delivery of NPs, endosomal …

It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …

The aims of this work were (i) to evaluate the potential of nanostructured lipid carriers
(NLCs) as a tool to enhance the oral bioavailability of poorly soluble compounds using …

Niosomes represent a recent promising approach for gene delivery purposes. We
elaborated on a novel niosome formulation based on the 2, 3-di (tetradecyloxy) propan-1 …

Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have been
recognized, among the large number of non-viral vectors for gene transfection, as an …

Solid lipid nanoparticles (SLN) were invented in 1991 as a delivery system combining
advantages of other nanoparticulate systems and at the same time avoiding/minimizing …

Nanoparticles (NPs) comprised of nanoengineered complexes are providing new
opportunities for enabling targeted delivery of a range of therapeutics and combinations. A …

X-linked juvenile retinoschisis (XLRS) is a retinal degenerative disorder caused by
mutations in the RS1 gene encoding a protein termed retinoschisin. The disease is an …